Seizure in Medical Technology
Navigation Links
Seizure in Medical Technology
... resulted
in a marked and sustained decrease in seizure frequency over the long-term(1).
Results ... add-on treatment experienced a
mean reduction in seizure frequency of more than 61% (95%CI: ... had achieved at least a 50% reduction in seizure frequency with
Zebinix(R) treatment(1).
...
... treatment success is not only determined by seizure control, but equally by tolerability, which is ... demonstrate benefit of carisbamate in reducing seizure frequency in some patients with partial onset ... endpoints were median percent reduction in seizure frequency in the double blind phase compared to ...
... Ohio. "Existing antiepileptics offer limited seizure control and there may be difficulties with ... AEDs. The median percentage reduction in total seizure frequency from baseline was greater in the ... 42.5% median percentage reduction in tonic-atonic seizure (drop attack) frequency per 28 days from baseline ...
... Keppra XR(TM) significantly reduced partial onset seizure frequency when administered as adjunctive ... tablets significantly reduced partial onset seizure frequency when administered as adjunctive therapy ... The study met its primary endpoint for seizure reduction over placebo during the treatment ...
... XR achieved at least a 50 percent reduction in seizure frequency compared to 24 percent of patients ... XR taken once- daily significantly reduced seizure frequency among previously uncontrolled patients. ... median percent reduction from baseline in partial seizure frequency. Study results showed that Lamictal ...
... NUCYNTA(TM) has not been systematically evaluated in patients with a seizure disorder, and such patients were excluded from clinical studies. NUCYNTA(TM) should be prescribed with care in patients with a history of a seizure disorder or any condition that would put the patient at risk of seizures. ...
... RISPERDAL(R) CONSTA(R) should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that ... with a history of seizures or with conditions that potentially lower seizure threshold. Dysphagia: Esophageal dysmotility and aspiration can ...
... included. These variations can mean the difference between being seizure free and suddenly having a seizure while driving on the freeway," said Dr. Brien Smith, Senior Staff ...
... oral antiepileptic drug. In these circumstances, and in order to maintain seizure control, a short-term, alternative administration of their antiepileptic ... significantly greater 50% responder rates and reductions in median seizure frequency were seen versus placebo. The most common adverse events of ...
... before talking to your healthcare professional. Avoid alcohol while on paliperidone. Paliperidone should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures. Extrapyramidal Symptoms (EPS) are ...
... by recurrent, unprovoked seizures, is a change in sensation, awareness or behavior caused by an electrical disturbance in the brain. The kind of seizure a person has depends on which part and how much of the brain is affected by the disturbance. Primary generalized seizures involve the entire brain ...
... to other erythropoietic proteins. The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes, or hypercoagulable disorders). In some ...
... erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes, or hypercoagulable disorders). -- In ...
... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains ...
... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains ...
... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains ...
... Due to the voluntary nature of these reports it is not possible to reliably estimate frequency or establish a causal relationship. Increased seizure activity or decreased phenytoin levels have been reported in patients receiving phenytoin concomitantly with Welchol. Reduced International ...
... Due to the voluntary nature of these reports it is not possible to reliably estimate frequency or establish a causal relationship. Increased seizure activity or decreased phenytoin levels have been reported in patients receiving phenytoin concomitantly with Welchol. Reduced International ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... Due to the voluntary nature of these reports it is not possible to reliably estimate frequency or establish a causal relationship. Increased seizure activity or decreased phenytoin levels have been reported in patients receiving phenytoin concomitantly with Welchol. Reduced International ...
... seizures (ARS) are bouts of acute seizure activity occurring within a 24-hour period in adults and a 12-hour period in children. ARS, also called seizure clusters, occurs in a small subset of patients with epilepsy who regularly experience breakthrough seizures in flurries or clusters despite treatment ...
Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
... in helping patients move closer to the goal of seizure freedom," said Steven S. Chung, MD, Director of ... those recently diagnosed who have not achieved seizure control on current therapy, to those who have ... with epilepsy, less than half (47%) attained seizure control with the first AED More than 30% ...... treatment success is not only determined by seizure control, but equally by tolerability, which is ... demonstrate benefit of carisbamate in reducing seizure frequency in some patients with partial onset ... endpoints were median percent reduction in seizure frequency in the double blind phase compared to ...
New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy
... and demonstrated sustained reduction in partial seizure frequency during a one-year open label ... a patient's day-to-day life, as well as effective seizure control," said Professor E. Ben-Menachem, ... Sweden. "In addition to sustained reductions in seizure frequency, Zebinix(TM) also demonstrated ...... Ohio. "Existing antiepileptics offer limited seizure control and there may be difficulties with ... AEDs. The median percentage reduction in total seizure frequency from baseline was greater in the ... 42.5% median percentage reduction in tonic-atonic seizure (drop attack) frequency per 28 days from baseline ...
Status of the E2007 (perampanel) Development Program
... pentylenetetrazole, audiogenic and kindling seizure models) suggested that perampanel may ... seizures. There was a 40% median seizure reduction in the perampanel arm and a 2% median seizure increase in the placebo arm. The responder rate, ...Keppra XR(TM) Extended-Release Tablets Filed with the FDA
... The study met its primary endpoint for seizure reduction over placebo during the treatment ... to the extended-release levetiracetam group had seizure frequency per week reduced by 75-100%, compared ... seizures and 8.9% were free from any type of seizure over the treatment period, compared to 2.5% and ....... Keppra XR(TM) significantly reduced partial onset seizure frequency when administered as adjunctive ... tablets significantly reduced partial onset seizure frequency when administered as adjunctive therapy ... The study met its primary endpoint for seizure reduction over placebo during the treatment ...
... XR achieved at least a 50 percent reduction in seizure frequency compared to 24 percent of patients ... XR taken once- daily significantly reduced seizure frequency among previously uncontrolled patients. ... median percent reduction from baseline in partial seizure frequency. Study results showed that Lamictal ...
... NUCYNTA(TM) has not been systematically evaluated in patients with a seizure disorder, and such patients were excluded from clinical studies. NUCYNTA(TM) should be prescribed with care in patients with a history of a seizure disorder or any condition that would put the patient at risk of seizures. ...
... RISPERDAL(R) CONSTA(R) should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that ... with a history of seizures or with conditions that potentially lower seizure threshold. Dysphagia: Esophageal dysmotility and aspiration can ...
... included. These variations can mean the difference between being seizure free and suddenly having a seizure while driving on the freeway," said Dr. Brien Smith, Senior Staff ...
New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures
... should be gradually withdrawn to minimize the potential of increased seizure frequency. Dosing must be individualized according to the ... and defined by two or more unprovoked seizures. There are many different seizure types and epileptic syndromes. Forty percent of patients taking only one ...... oral antiepileptic drug. In these circumstances, and in order to maintain seizure control, a short-term, alternative administration of their antiepileptic ... significantly greater 50% responder rates and reductions in median seizure frequency were seen versus placebo. The most common adverse events of ...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
... a car, operating machines, or doing things that require you to be alert. INVEGA((R)) SUSTENNA(TM) should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures. Call your doctor right away if you ...Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains ...... before talking to your healthcare professional. Avoid alcohol while on paliperidone. Paliperidone should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures. Extrapyramidal Symptoms (EPS) are ...
... by recurrent, unprovoked seizures, is a change in sensation, awareness or behavior caused by an electrical disturbance in the brain. The kind of seizure a person has depends on which part and how much of the brain is affected by the disturbance. Primary generalized seizures involve the entire brain ...
... to other erythropoietic proteins. The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes, or hypercoagulable disorders). In some ...
FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
... potentially hazardous tasks such as driving a car or operating machinery. Tapentadol should be prescribed with care in patients with a history of a seizure disorder or any condition that would put the patient at risk of seizures. The development of a potentially life-threatening serotonin ...... erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes, or hypercoagulable disorders). -- In ...
New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
... management, as clinically indicated. Carbapenems may reduce serum valproic acid concentrations to subtherapeutic levels, resulting in loss of seizure control. Serum valproic acid concentrations should be monitored frequently after initiating carbapenem therapy. Alternative antibacterial or ...... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains ...
... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains ...
... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains ...
FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia
... management, as clinically indicated. Carbapenems may reduce serum valproic acid concentrations to subtherapeutic levels, resulting in loss of seizure control. Serum valproic acid concentrations should be monitored frequently after initiating carbapenem therapy. Alternative antibacterial or ...... Due to the voluntary nature of these reports it is not possible to reliably estimate frequency or establish a causal relationship. Increased seizure activity or decreased phenytoin levels have been reported in patients receiving phenytoin concomitantly with Welchol. Reduced International ...
... Due to the voluntary nature of these reports it is not possible to reliably estimate frequency or establish a causal relationship. Increased seizure activity or decreased phenytoin levels have been reported in patients receiving phenytoin concomitantly with Welchol. Reduced International ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
... allergic reactions have been seen in some patients during ELAPRASE infusions. Reactions included difficulty breathing, lack of oxygen, seizure or loss of consciousness, hives, and/or swelling of the throat or tongue. Patients received an antihistamine to reverse the allergic reaction or ...Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease
... new onset or exacerbation of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with Cimzia(R); the causal relationship to Cimzia(R) ...... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...
... Due to the voluntary nature of these reports it is not possible to reliably estimate frequency or establish a causal relationship. Increased seizure activity or decreased phenytoin levels have been reported in patients receiving phenytoin concomitantly with Welchol. Reduced International ...
... seizures (ARS) are bouts of acute seizure activity occurring within a 24-hour period in adults and a 12-hour period in children. ARS, also called seizure clusters, occurs in a small subset of patients with epilepsy who regularly experience breakthrough seizures in flurries or clusters despite treatment ...
PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting
... to other erythropoietic proteins. -- The safety and efficacy of PROCRIT therapy have not been established in patients with a known history of a seizure disorder or underlying hematologic disease (e.g., sickle cell anemia, myelodysplastic syndromes or hypercoagulable disorders). -- In some ...This Thanksgiving Give the Gift of Good Health - Remind Family and Friends to Get a Flu Shot.
... cancer treatments) -- Adults and children who have certain muscle or nerve disorders (e.g. cognitive dysfunction, spinal cord injuries, seizure disorders, or other neuromuscular disorders) that can compromise respiratory function or the handling of respiratory secretions or that can ...Other ContentsenhancerenhancerenhancerenhancerenhancerenhancerepidermisepidermisepidermisepidermisepidermisalcoholalcoholalcoholalcoholalcoholalcoholalcoholalcoholalcoholethylethylethylepigeneticsbacteriumbacteriumbacteriumbacteriumbacteriumbacteriumeugenicseukaryoteOther TagsBioChemiBioChemiSonySonyOther Tagspropose 2propose 3propose 4chain 2chain 3chain 4chain 5chain 6chain 7gray 2pain 2pain 3pain 4pain 5pain 6pain 7chronic 2chronic 3chronic 4chronic 5chronic 6chronic 7chronic 8chronic 9chronic 10
(Date:11/4/2009)..., LEADS: (top news in natural science) , Un... States uses less water today than it did 35 years...clines in water use are partly attributable to alt...efficient irrigation systems. According to the lat...r used in the United States goes to cooling thermo...
(Date:11/4/2009)... St. Louis, MO, November 4, 2009 Childhood obesi...rtions. With more than one fourth of advertising o...ds and beverages and continuing questions about th... November/December issue of the Journal of Nutrit...rtising aimed at children might be a large contrib...
(Date:11/4/2009)... The Singapore laboratory that deciphered the DNA...sh) and elephant shark, has joined The Genome 10K ...uable repository of DNA sequences on 10,000 specie... a scale that currently can not be achieved. , P...in a paper published in the Nov. 5, 2009 issue of ...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Singapore scientists join international study of 10,000 vertebrates' genomes 2Colorectal Cancer Rates Rising for Under 50 Set 48222 1Colorectal Cancer Rates Rising for Under 50 Set 48222 2Colorectal Cancer Rates Rising for Under 50 Set 48222 3Cardiac rehabilitation saves lives 48219 1Cardiac rehabilitation saves lives 48219 2Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 1Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 2Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 3(Date:11/8/2009)...en Medicare, improve coverage for all Americans ,...SUMMARY: Yesterday the United States House of Rep...gislation that would strengthen Medicare for senio...hat prices millions of Americans out of affordable...re for America Act (H.R. 3962) makes prescription ...
(Date:11/8/2009)...ealth holds open house at Victoria campus , ..., 2009 -- UCW Academy of Health invites anyone loo... health care industry to attend their open house i...W Academy of Health, which offers diplomas in area...ces, designs its programs to meet the needs of the...
(Date:11/8/2009)...swire/ -- Tonight the House of Representatives pas...ndmark health reform legislation that will ensure ...stable and secure health care coverage. The legisl...industry,s worst practices, would extend coverage ...4 billion over ten years. Groups representing doct...
(Date:11/8/2009)...th Network (MHN) urges military veterans to learn ...to exposure to chemicals, atomic agents and soot o...ne of those cancers that is two times more prevale...r currently smoke cigarettes. , ...en’s Health Network (MHN) kicked-off their V...
(Date:11/8/2009)...c health advocates committed to achieving meaningf...ov. 7 "Tonight the U.S....he voice of America,s families by passing the Affo... must deliver, without delay, on the promise of me...gado, President and CEO of the National Alliance f...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2[1] AARP NY Praises House Passage of Health Care Reform Bill[0] College Invites Public to Explore Career Options in Health Care[0] Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform[0] Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors [0] National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |